New England Peptide, SISCAPA Collaborate on Peptide Standards | GenomeWeb

NEW YORK (GenomeWeb) – New England Peptide and SISCAPA Assay Technologies are collaborating to manufacture and sell stable isotope standard peptides for use in SISCAPA's protein quantification assays.

Under the terms of the deal announced today, NEP will manufacture peptide standards that can be used on the assays. The peptides will be used with SISCAPA's validated monoclonal anti-peptide antibodies so that licensees of SISCAPA's will have standardized, high-sensitivity measurements of proteins by mass spectrometry, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.